MedTrace Logo

Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes

NCT01771939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-01-18

No results posted yet for this study

Summary

The purpose of the study is to evaluate the difference in Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, oct retinal thickness and microperimetry in 2 groups of 30 eyes each affected by idiopathic epiretinal membranes that underwent phacoemulsification and 25G pars-plana vitrectomy with internal limiting membrane (ILM) peeling (Group 1) versus phacoemulsification only (Group 2), with a follow-up length up to 5 years.

Conditions

  • Epiretinal Membrane

Interventions

PROCEDURE

25-G vitrectomy and phacoemulsification

25-G vitrectomy with Internal Limiting Membrane peeling and phacoemulsification (cataract intervention)

PROCEDURE

phacoemulsification (cataract surgery)

lens extraction after phacoemulsification and intra-ocular artificial lens implantation

Sponsors & Collaborators

  • University of Turin, Italy

    lead OTHER

Principal Investigators

  • Marco Dal Vecchio, MD · Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy 10100

  • Antonio M. Fea, MD, PhD · Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy

  • Carlo A Lavia, MD · Clinica Oculistica dell'Università, Ospedale Oftalmico Turin, Italy

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2006-11-30
Completion
2012-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771939 on ClinicalTrials.gov